Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on April 28, 2025
The Brookbush Institute Publishes NEW Course and Glossary Updates: 'Anatomical Directions'
EIN Presswire
·
April 28, 2025
The Brookbush Institute continues to enhance education with new courses, a modern glossary, an AI Tutor, and a client program generator. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- - Excerpt from the glossary term: Anatomical …
Osmosis Launches Limited-Edition Summer Cooling Enzyme Mask for Skincare Professionals
EIN Presswire
·
April 28, 2025
Watermelon-Infused Formula Offers Seasonal Skincare Solution with Exclusive April Promotion NEW YORK CITY, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- Osmosis, a leading professional skincare brand, announces the launch of its limited- …
U.S. Amputee Soccer Names 2026 World Cup Qualifiers Roster, Launches Fundraiser for Mexico
EIN Presswire
·
April 28, 2025
STONY BROOK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- The American Amputee Soccer Association is proud to announce the official roster of players who will represent the United States in the 2026 Amputee Soccer World Cup Qualifiers, to be …
EricMalley.com Reveals $611 Billion Digital Marketing Inefficiency in TechBullion Feature Article
EIN Presswire
·
April 28, 2025
New Four-Part Series Launches “Spherical Philosophy™” to Transform How Businesses Integrate AI and Geographic Engine Optimization NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- Digital marketing expert Eric Malley has published a …
Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board
GlobeNewswire
·
April 28, 2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has appointed Lyn Cobley to its Board of Directors. Ms. Cobley has been a …
CD Bioparticles Introduces New Range of Kits for Advanced Exosome Labeling & Purification
EIN Presswire
·
April 28, 2025
CD Bioparticles has announced the launch of its new comprehensive line of kits for Exosome Labeling …
CD Bioparticles Announces Custom Synthesis Service for Magnetic Sodium Alginate Hydrogel Particles
EIN Presswire
·
April 28, 2025
CD Bioparticles announces new service for custom synthesis and drug encapsulation of Magnetic Sodium Alginate Hydrogel Particles. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- With years of experience in the pharmaceutical and life …
STEMart Advances Research and Development with Comprehensive Microfluidics Services
EIN Presswire
·
April 28, 2025
STEMart has announced its Microfluidics Service for microfluidics application, device development, and manufacturing. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- STEMart, a US-based provider of comprehensive services for all phases …
Creative Diagnostics Launches Monkeypox Virus Neutralizing Antibody Test Services to Aid in Immune Response Assessment
EIN Presswire
·
April 28, 2025
Creative Diagnostics has announced Monkeypox Virus Neutralizing Antibody Test services for monkeypox research. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- As an expert in providing solutions to assist virology and microbiology …
Creative Diagnostics Introduces Advanced tRNA Modification Detection Solutions to Support Genetic Research
EIN Presswire
·
April 28, 2025
Creative Diagnostics has announced its highly validated antibodies for tRNA Modification Detection. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and …
UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine
GlobeNewswire
·
April 28, 2025
LONDON, April 29, 2025 (GLOBE NEWSWIRE) -- Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Phase 1, first-in-human clinical trial led by …
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
GlobeNewswire
·
April 28, 2025
MELBOURNE, Australia, April 29, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET1 imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide …
IntegrateRNA offers improved protein engineering capabilities through their sophisticated ncAA-tRNA modification system
EIN Presswire
·
April 28, 2025
NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- The Creative Biogene division IntegrateRNA launched a novel platform that enables post-translational protein modification through the use of non-canonical amino acids and engineered transfer RNA. …
ElevateBio Announces Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
GlobeNewswire
·
April 28, 2025
– Oral and poster presentations will highlight advancements from ElevateBio’s two business units: Life Edit, its gene editing and R…
ARCPOINT REPORTS 2024 YEAR END FINANCIAL RESULTS AND ANNOUNCES MANAGEMENT CHANGE
GlobeNewswire
·
April 28, 2025
Greenville, South Carolina, April 28, 2025 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) is pleased to report that it has filed its 2024 year end, audited Financial Statements and related Management Discussion and Analysis as …
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting
GlobeNewswire
·
April 28, 2025
WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with …
Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025
GlobeNewswire
·
April 28, 2025
NEW YORK, 28 avr. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS - NASDAQ : CLLS) (la "Société"), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome pour développer des thérapies cellulaires …
Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion
GlobeNewswire
·
April 28, 2025
Reflects business philosophy of commercial success through patient accessibility Recently executed agreement with CD 8 Technology Services LLC providing up to $50 million for Company’s dedicated R&D and manufacturing facility; no impact on shareholder …
Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
GlobeNewswire
·
April 28, 2025
Prolonged duration of response, deep B-cell depletion, and well-tolerated safety profile support the potential of AlloNK® + rituximab for the treatment of B-cell driven diseases in a community setting Additional poster presentation to feature scalability …
Arbor Biotechnologies to Present Foundational Data for PH1 and CNS Programs at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
GlobeNewswire
·
April 28, 2025
- Oral presentation to include preclinical data supporting the clinical advancement of ABO-101 for the treatment of primary hyperoxaluria type 1 - Four poster presentations collectively demonstrate advancement of company’s differentiated CNS gene editing …